Vestor Capital LLC bought a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,700 shares of the company’s stock, valued at approximately $153,000.
Several other hedge funds and other institutional investors have also recently modified their holdings of TEM. Dakota Wealth Management bought a new position in Tempus AI in the 3rd quarter valued at $1,185,000. Davidson Kempner Capital Management LP bought a new position in shares of Tempus AI in the second quarter worth about $2,271,000. NEA Management Company LLC bought a new stake in Tempus AI during the 2nd quarter valued at about $160,048,000. Exchange Traded Concepts LLC purchased a new stake in Tempus AI in the 3rd quarter valued at about $3,458,000. Finally, Sculptor Capital LP bought a new position in Tempus AI in the 2nd quarter worth about $5,085,000.
Wall Street Analysts Forecast Growth
Several research analysts have commented on TEM shares. JPMorgan Chase & Co. raised their price objective on Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Morgan Stanley started coverage on Tempus AI in a report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective for the company. Bank of America downgraded shares of Tempus AI from a “buy” rating to a “neutral” rating and raised their target price for the company from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Longbow Research began coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price target for the company. Finally, William Blair assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set an “outperform” rating on the stock. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Tempus AI has an average rating of “Moderate Buy” and a consensus price target of $48.67.
Tempus AI Price Performance
Tempus AI stock opened at $46.05 on Monday. The stock has a fifty day simple moving average of $50.70. Tempus AI, Inc. has a 1-year low of $22.89 and a 1-year high of $77.00. The company has a quick ratio of 3.52, a current ratio of 3.70 and a debt-to-equity ratio of 4.50.
Tempus AI (NASDAQ:TEM – Get Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The firm had revenue of $165.97 million for the quarter, compared to analysts’ expectations of $159.10 million. Research analysts anticipate that Tempus AI, Inc. will post -6.51 EPS for the current fiscal year.
Tempus AI Company Profile
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
- Five stocks we like better than Tempus AI
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Enovix Targets Silicon Anode Battery Launch As AI Drives Demand
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Tasty Stocks with Long Term Growth and Stable Dividends
- There Are Different Types of Stock To Invest In
- Why Gold Prices Could Surge to $3,000: Key Drivers for Bulls
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.